Overdose death & incident reporting
Act 126 of 2020 updated the previous Methadone Death and Incident Review law to include a review of death and incidents related to FDA-approved medications as a primary, secondary or contributing factor to the death or incident. The following resources were developed by the MDAIR Team for the reporting of medication death and incidents related to FDA-approved medications for Opioid Use Disorder (MOUD) (buprenorphine, naltrexone, or methadone) where MOUD was the cause or contributing factor to the death or incident.
Medication death and incident reporting
Members of the general public can report a medication-related death or incident that involves MOUD using the form below.
- Medication Death and Incident General Public Reporting Form **This form is not currently available.
- In the meantime, please use this Word version and email to RA‐DAOD@pa.gov
Coroner's MOUD-related death report
A county coroner or medical examiner shall forward all MOUD-related death cases to DDAP's MDAIR Team for review.
*The coroner or medical examiner is only required to submit death reports involving FDA-approved MOUD that were a cause or contributing factor to the death.